Under the tradename of Chiralscreen™, Daicel is introducing a formate dehydrogenase which by protein engineering techniques has a high selectivity for NADPH regeneration. The development was done in collaboration with Prof. Koji ISHIHARA of Okayama University.
Daicel Exibition Information, JSBBA Meeting Sendai, March 27, 2013
Daicel to market engineered formate dehydrogenase with NADPH regeneration capacity